CNTA vs OKTA · $6.15B cap vs P/E 84, rev $1.57B
Centessa Pharmaceuticals PLC ADR (CNTA) versus Okta Inc (OKTA) — a side-by-side from cached financials, not a winner call.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
CNTA currently screens at market cap $6.15B. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Not investment advice. Open the CNTA and OKTA stock pages for the full models.
Not investment advice.